AB
ALLO icon

Amalgamated Bank’s Allogene Therapeutics ALLO Stock Holding History

Amalgamated Bank’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,833
Closed -$7K – 1663
2025
Q4 		$7K Buy
4,833
+403
+9% +$532 ﹤0.01% 2557
2025
Q3 		$5K Hold
4,430
– – ﹤0.01% 2734
2025
Q2 		$5K Hold
4,430
– – ﹤0.01% 2709
2025
Q1 		$6K Buy
4,430
+1,664
+60% +$3.14K ﹤0.01% 2562
2024
Q4 		$6K Hold
2,766
– – ﹤0.01% 2636
2024
Q3 		$8K Hold
2,766
– – ﹤0.01% 2532
2024
Q2 		$6K Hold
2,766
– – ﹤0.01% 2662
2024
Q1 		$12K Sell
2,766
-4,397
-61% -$18.3K ﹤0.01% 2341
2023
Q4 		$23K Sell
7,163
-823
-10% -$2.33K ﹤0.01% 2577
2023
Q3 		$25K Hold
7,986
– – ﹤0.01% 2534
2023
Q2 		$40K Sell
7,986
-260
-3% -$1.41K ﹤0.01% 2408
2023
Q1 		$41K Sell
8,246
-1,946
-19% -$12.5K ﹤0.01% 2376
2022
Q4 		$64K Hold
10,192
– – ﹤0.01% 2311
2022
Q3 		$110K Buy
10,192
+99
+1% +$1.34K ﹤0.01% 2108
2022
Q2 		$115K Buy
10,093
+743
+8% +$6.59K ﹤0.01% 2108
2022
Q1 		$85K Sell
9,350
-736
-7% -$7.67K ﹤0.01% 2254
2021
Q4 		$150K Sell
10,086
-98
-1% -$1.73K ﹤0.01% 2011
2021
Q3 		$262K Sell
10,184
-691
-6% -$16.4K ﹤0.01% 1892
2021
Q2 		$284K Buy
10,875
+3,199
+42% +$91.2K ﹤0.01% 1912
2021
Q1 		$271K Sell
7,676
-750
-9% -$25.3K 0.01% 1327
2020
Q4 		$213K Buy
8,426
+46
+0.5% +$1.5K 0.01% 1418
2020
Q3 		$316K Buy
8,380
+618
+8% +$23.3K 0.01% 1084
2020
Q2 		$332K Buy
+7,762
New +$281K 0.02% 1051

Other funds holding ALLO

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amalgamated Bank's ALLO Position: Q1 2026 in Review

Amalgamated Bank sold out of Allogene Therapeutics (ALLO) in Q1 2026, closing a stake of 4,833 shares — an estimated $7K sold.

Amalgamated Bank first reported a position in ALLO in Q2 2020 and held it in 23 quarters. The position peaked at $332K in Q2 2020. 209 funds tracked by Wall St. Rank hold ALLO as of Q1 2026.

  • Amalgamated Bank reported no remaining Allogene Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 4,833 Allogene Therapeutics shares in Q1 2026, an estimated $7K.
  • Amalgamated Bank first reported a position in Allogene Therapeutics in Q2 2020 and held it in 23 quarters.
  • Amalgamated Bank's Allogene Therapeutics position peaked at $332K in Q2 2020.
  • 209 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.